Edition:
United Kingdom

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

680.00GBp
4:35pm BST
Change (% chg)

0.00 (+0.00%)
Prev Close
680.00
Open
680.00
Day's High
687.00
Day's Low
665.00
Volume
70,240
Avg. Vol
68,090
52-wk High
1,064.38
52-wk Low
575.32

Latest Key Developments (Source: Significant Developments)

Oxford Biomedica's FY Gross Income Increased By 72 Pct
Thursday, 14 Mar 2019 

March 14 (Reuters) - Oxford BioMedica PLC ::PRELIMINARY RESULTS.FY GROSS INCOME INCREASED BY 72% TO £67.9 MILLION (2017: £39.4 MILLION).FY REVENUE INCREASED BY 78% TO £66.8 MILLION (2017: £37.6 MILLION).FY ADJUSTED OPERATING EXPENSES INCREASED BY 38% TO £31.7 MILLION (2017: £22.9 MILLION).FY OPERATING EBITDA OF £13.4 MILLION (2017: OPERATING EBITDA LOSS OF £1.9 MILLION).YEAR-END INVENTORIES INCREASED DUE ONGOING BIOPROCESSING COMMITMENTS ACROSS 2018 AND INTO 2019 FOR BREXIT PLANNING.GROUP HAS ASSESSED FUTURE IMPACT OF BREXIT ON ITS OPERATIONS TO BE MINOR.  Full Article

Patrick Machado Says Axovant Sciences Agreed To Sell To Roivant 14.3 Mln Shares
Thursday, 7 Jun 2018 

June 7 (Reuters) - Patrick Machado::PATRICK MACHADO SAYS ON JUNE 5, ROIVANT ENTERED SHARE PURCHASE AGREEMENT - SEC FILING.PATRICK MACHADO SAYS AXOVANT SCIENCES AGREED TO ISSUE, SELL TO ROIVANT 14.3 MILLION SHARES AT $1.75/ SHARE IN A PRIVATE PLACEMENT.PATRICK MACHADO SAYS ROIVANT PROVIDED FINANCING WITH AXOVANT'S ENTRY TO LICENSE AGREEMENT WITH OXFORD BIOMEDICA.PATRICK MACHADO - ROIVANT REMAINS DIRECT OWNER OF 89.3 MILLION SHARES OF AXOVANT, INCLUDING 75 MILLION SHARES BENEFICIALLY OWNED BEFORE AXOVANT’S IPO.PATRICK MACHADO SAYS SHARES DISPOSITIVE POWER OVER ROIVANT’S 89.3 MILLION SHARES OF AXOVANT WITH OTHER INDEPENDENT DIRECTOR OF ROIVANT CURRENTLY SERVING.  Full Article

Oxford Biomedica Announces ‍Proposed Placing To Raise About 20.5 Mln STG
Friday, 9 Mar 2018 

March 9 (Reuters) - Oxford Biomedica Plc ::OXFORD BIOMEDICA PLC - ‍PROPOSED PLACING TO RAISE APPROXIMATELY £20.5 MILLION​.OXFORD BIOMEDICA - TO RAISE ABOUT £20.5 MILLION BY WAY OF CONDITIONAL PLACING OF UP TO 174.3 MILLION NEW SHARES AT A PRICE OF 11.75 PENCE PER PLACING SHARE​.OXFORD BIOMEDICA PLC - PLACING ‍TO FUND EXPANSION OF ITS BIOPROCESSING FACILITIES​.  Full Article

Oxford Biomedica Says ‍Kymriah Receives Priority Review For Adult DLBCL​
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Oxford Biomedica Plc ::SAYS ‍KYMRIAH RECEIVES PRIORITY REVIEW FOR ADULT DLBCL​.  Full Article

Oxford Biomedica says Stuart Paynter joins group as CFO
Tuesday, 29 Aug 2017 

Aug 29 (Reuters) - Oxford Biomedica Plc :STUART PAYNTER TODAY JOINS GROUP AS CHIEF FINANCIAL OFFICER AND MEMBER OF BOARD OF DIRECTORS.TIM WATTS, OUTGOING CFO WILL REMAIN UNTIL 29 SEPTEMBER 2017 AT WHICH POINT HE WILL STEP DOWN FROM BOARD AND LEAVE GROUP.  Full Article

Oxford Biomedica completes new $55 million debt facility
Friday, 30 Jun 2017 

June 30 (Reuters) - Oxford Biomedica Plc ::Completed a new $55 million debt facility with Oaktree Capital Management - Strategic Credit Strategy.Facility has been used to redeem existing debt facility with Oberland Capital Healthcare.  Full Article

BRIEF-Oxford Biomedica Says Japanese Approval Of Kymriah

* NOTES AN ANNOUNCEMENT BY NOVARTIS THAT JAPAN'S MINISTRY OF HEALTH, LABOR AND WELFARE (MHLW) HAS APPROVED KYMRIAH Source text for Eikon: Further company coverage: